Metabotropic Glutamate Receptor 5 in Amygdala Target Neurons Regulates Susceptibility to Chronic Social Stress

被引:24
|
作者
Kim, Jeongseop [1 ,2 ]
Kang, Shinwoo [3 ,4 ,5 ,6 ]
Choi, Tae-Yong [1 ]
Chang, Keun-A [3 ,4 ,5 ]
Koo, Ja Wook [1 ,2 ]
机构
[1] Korea Brain Res Inst, Emot Cognit & Behav Res Grp, Daegu, South Korea
[2] Daegu Gyeongbuk Inst Sci & Technol, Dept Brain & Cognit Sci, Daegu, South Korea
[3] Gachon Univ, Coll Med, Dept Pharmacol, Incheon, South Korea
[4] Gachon Univ, Neurosci Res Inst, Incheon, South Korea
[5] Gachon Univ, GAIHST, Dept Hlth Sci & Technol, Incheon, South Korea
[6] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA
基金
新加坡国家研究基金会;
关键词
MAJOR DEPRESSIVE DISORDER; PREFRONTAL CORTEX; FUNCTIONAL CONNECTIVITY; ANIMAL-MODELS; LIFE EVENTS; HIPPOCAMPUS; RESILIENCE; EXPRESSION; MGLUR5; REWARD;
D O I
10.1016/j.biopsych.2022.01.006
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BACKGROUND: Metabotropic glutamate receptor 5 (mGluR5) has been implicated in stress-related psychiatric disorders, particularly major depressive disorder. Although growing evidence supports the proresilient role of mGluR5 in corticolimbic circuitry in the depressive-like behaviors following chronic stress exposure, the underlying neural mechanisms, including circuits and molecules, remain unknown. METHODS: We measured the c-Fos expression and probability of neurotransmitter release in and from basolateral amygdala (BLA) neurons projecting to the medial prefrontal cortex (mPFC) and to the ventral hippocampus (vHPC) after chronic social defeat stress. The role of BLA projections in depressive-like behaviors was assessed using optogenetic manipulations, and the underlying molecular mechanisms of mGluR5 and downstream signaling were investigated by Western blotting, viral-mediated gene transfer, and pharmacological manipulations. RESULTS: Chronic social defeat stress disrupted neural activity and glutamatergic transmission in both BLA projections. Optogenetic activation of BLA projections reversed the detrimental effects of chronic social defeat stress on depressive-like behaviors and mGluR5 expression in the mPFC and vHPC. Conversely, inhibition of BLA projections of mice undergoing subthreshold social defeat stress induced a susceptible phenotype and mGluR5 reduction. These two BLA circuits appeared to act in an independent way. We demonstrate that mGluR5 overexpression in the mPFC or vHPC was proresilient while the mGluR5 knockdown was prosusceptible and that the proresilient effects of mGluR5 are mediated through distinctive downstream signaling pathways in the mPFC and vHPC. CONCLUSIONS: These findings identify mGluR5 in the mPFC and vHPC that receive BLA inputs as a critical mediator of stress resilience, highlighting circuit-specific signaling for depressive-like behaviors.
引用
收藏
页码:104 / 115
页数:12
相关论文
共 50 条
  • [1] METABOTROPIC GLUTAMATE RECEPTOR 5 AS A POTENTIAL TARGET IN ALS
    Bonifacino, T.
    Milanese, M.
    Puliti, A.
    Melone, M.
    Rebosio, C.
    Provenzano, F.
    Torazza, C.
    Usai, C.
    Conti, F.
    Bonanno, G.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 63 - 64
  • [2] Metabotropic glutamate receptor 5: a target for migraine therapy
    Waung, Maggie W.
    Akerman, Simon
    Wakefield, Mark
    Keywood, Charlotte
    Goadsby, Peter J.
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2016, 3 (08): : 560 - 571
  • [3] Central Amygdala Metabotropic Glutamate Receptor 5 in the Modulation of Visceral Pain
    Crock, Lara W.
    Kolber, Benedict J.
    Morgan, Clinton D.
    Sadler, Katelyn E.
    Vogt, Sherri K.
    Bruchas, Michael R.
    Gereau, Robert W.
    JOURNAL OF NEUROSCIENCE, 2012, 32 (41): : 14217 - 14226
  • [4] Metabotropic glutamate receptor 5 as a potential target for smoking cessation
    Chiamulera, Cristiano
    Marzo, Claudio Marcello
    Balfour, David J. K.
    PSYCHOPHARMACOLOGY, 2017, 234 (9-10) : 1357 - 1370
  • [5] Glutamate Delta-1 Receptor Regulates Metabotropic Glutamate Receptor 5 Signaling in the Hippocampus
    Suryavanshi, Pratyush S.
    Gupta, Subhash C.
    Yadav, Roopali
    Kesherwani, Varun
    Liu, Jinxu
    Dravid, Shashank M.
    MOLECULAR PHARMACOLOGY, 2016, 90 (02) : 96 - 105
  • [6] Metabotropic glutamate receptor 5 as a potential target for smoking cessation
    Cristiano Chiamulera
    Claudio Marcello Marzo
    David J. K. Balfour
    Psychopharmacology, 2017, 234 : 1357 - 1370
  • [7] Blocking metabotropic glutamate receptor subtype 5 relieves maladaptive chronic stress consequences
    Peterlik, Daniel
    Stangl, Christina
    Bauer, Amelie
    Bludau, Anna
    Keller, Jana
    Grabski, Dominik
    Killian, Tobias
    Schmidt, Dominic
    Zajicek, Franziska
    Jaeschke, Georg
    Lindemann, Lothar
    Reber, Stefan O.
    Flor, Peter J.
    Uschold-Schmidt, Nicole
    BRAIN BEHAVIOR AND IMMUNITY, 2017, 59 : 79 - 92
  • [8] Metabotropic glutamate receptor 5 (mGluR5) regulates bladder nociception
    Crock, Lara W.
    Stemler, Kristina M.
    Song, David G.
    Abbosh, Philip
    Vogt, Sherri K.
    Qiu, Chang-Shen
    Lai, H. Henry
    Mysorekar, Indira U.
    Gereau, Robert W.
    MOLECULAR PAIN, 2012, 8
  • [9] Metabotropic glutamate receptor 5 as drug target for Fragile X syndrome
    Scharf, Sebastian H.
    Jaeschke, Georg
    Wettsteinl, Joseph G.
    Lindemann, Lothar
    CURRENT OPINION IN PHARMACOLOGY, 2015, 20 : 124 - 134
  • [10] Metabotropic Glutamate Receptor 5: A Potential Target for Neuropathic Pain Treatment
    Manengu, Chalton
    Zhu, Chun-Hao
    Zhang, Guo-Dong
    Tian, Miao-Miao
    Lan, Xiao-Bing
    Tao, Li-Jun
    Ma, Lin
    Liu, Yue
    Yu, Jian-Qiang
    Liu, Ning
    CURRENT NEUROPHARMACOLOGY, 2025, 23 (03) : 276 - 294